Asia Pacific Oral Antibiotics Market 2020-2030
Asia Pacific oral antibiotics market will grow by 4.6% annually with a total addressable market cap of $103.3 billion over 2020-2030
- Bonafide Trust
- 26-08-2020
- Pages : 126
- Figures : 62
- Tables : 35
- Region : Asia-Pacific
- Category : Lifescience
- Pharmaceutical
Asia Pacific oral antibiotics market will grow by 4.6% annually with a total addressable market cap of $103.3 billion over 2020-2030 owing to the rising infection complications associated with COVID-19 epidemic, development of innovative antibiotics, and growing healthcare expenditure. Highlighted with 35 tables and 62 figures, this 126-page report “Asia Pacific Oral Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific oral antibiotics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific oral antibiotics market in every aspect of the classification from perspectives of Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Application, Drug Type, and Country. Based on Drug Class, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Cephalosporin • Cefuroxime Axetil • Cephalexin • Cefixime • Cefpodoxime • Other Cephalosporin Penicillin Macrolides Tetracycline Quinolones Sulfonamides Aminoglycosides Other Drug Classes
What's Inside a Bonafide Research`s industry report?
Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally
Download SampleBased on Action Mechanism, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Cell Wall Synthesis Inhibitors • Mycolic Acid Inhibitors • RNA Synthesis Inhibitors • DNA Synthesis Inhibitors • Protein Synthesis Inhibitors • Other Mechanisms Based on Drug Origin, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Natural Antibiotics • Semi-synthetic Antibiotics • Synthetic Antibiotics Based on Activity Spectrum, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Broad-spectrum Antibiotics • Narrow-spectrum Antibiotics
Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Urinary Tract Infections (UTIS) • Upper Respiratory Tract Infections (URTI) • Lower Respiratory Tract Infections (LRTIs) Dental Infections • Monotherapies • Combined Therapies Respiratory Tract Infections (RTIS) Other Applications Based on Drug Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Brand Antibiotics • Generic Antibiotics Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Drug Class, Drug Origin, and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in Asia Pacific oral antibiotics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Abbott Laboratories Astellas Pharma AstraZeneca Plc Bayer AG Bristol Myers Squibb Company Cipla Inc. Dr. Reddy’s Laboratories Ltd. Eli Lilly and Company F. Hoffmann-La Roche Ltd. Gilead Sciences, Inc. GlaxoSmithKline plc. Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals) Mayne Pharma Group Ltd. MELINTA THERAPEUTICS, INC. Merck KGaA Novartis AG Pfizer Inc. Sanofi Sun Pharmaceutical Industries Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents
- 1 Introduction 7
- 1.1 Industry Definition and Research Scope 7
- 1.1.1 Industry Definition 7
- 1.1.2 Research Scope 8
- 1.2 Research Methodology 11
- 1.2.1 Overview of Market Research Methodology 11
- 1.2.2 Market Assumption 12
- 1.2.3 Secondary Data 12
- 1.2.4 Primary Data 12
- 1.2.5 Data Filtration and Model Design 14
- 1.2.6 Market Size/Share Estimation 15
- 1.2.7 Research Limitations 16
- 1.3 Executive Summary 17
- 2 Market Overview and Dynamics 20
- 2.1 Market Size and Forecast 20
- 2.1.1 Impact of COVID-19 on the Market 21
- 2.2 Major Growth Drivers 23
- 2.3 Market Restraints and Challenges 27
- 2.4 Emerging Opportunities and Market Trends 30
- 2.5 Porter’s Fiver Forces Analysis 34
- 3 Segmentation of Asia Pacific Market by Drug Class 38
- 3.1 Market Overview by Drug Class 38
- 3.2 Cephalosporin 40
- 3.3 Penicillin 42
- 3.4 Macrolides 43
- 3.5 Tetracycline 44
- 3.6 Quinolones 45
- 3.7 Sulfonamides 46
- 3.8 Aminoglycosides 47
- 3.9 Other Drug Classes 48
- 4 Segmentation of Asia Pacific Market by Action Mechanism 49
- 4.1 Market Overview by Action Mechanism 49
- 4.2 Cell Wall Synthesis Inhibitors 51
- 4.3 Mycolic Acid Inhibitors 52
- 4.4 RNA Synthesis Inhibitors 53
- 4.5 DNA Synthesis Inhibitors 54
- 4.6 Protein Synthesis Inhibitors 55
- 4.7 Other Mechanisms 56
- 5 Segmentation of Asia Pacific Market by Drug Origin 57
- 5.1 Market Overview by Drug Origin 57
- 5.2 Natural Antibiotics 59
- 5.3 Semi-synthetic Antibiotics 60
- 5.4 Synthetic Antibiotics 61
- 6 Segmentation of Asia Pacific Market by Activity Spectrum 62
- 6.1 Market Overview by Activity Spectrum 62
- 6.2 Broad-spectrum Antibiotics 64
- 6.3 Narrow-spectrum Antibiotics 65
- 7 Segmentation of Asia Pacific Market by Application 66
- 7.1 Market Overview by Application 66
- 7.2 Urinary Tract Infections (UTIS) 68
- 7.3 Dental Infections 69
- 7.3.1 Monotherapies for Dental Infections 70
- 7.3.2 Combined Therapies for Dental Infections 71
- 7.4 Respiratory Tract Infections (RTIS) 72
- 7.4.1 Upper Respiratory Tract Infections (URTI) 73
- 7.4.2 Lower Respiratory Tract Infections (LRTIs) 74
- 7.5 Other Applications 75
- 8 Segmentation of Asia Pacific Market by Drug Type 76
- 8.1 Market Overview by Drug Type 76
- 8.2 Brand Antibiotics 78
- 8.3 Generic Antibiotics 79
- 9 Asia-Pacific Market 2019-2030 by Country 80
- 9.1 Overview of Asia-Pacific Market 80
- 9.2 Japan 83
- 9.3 China 86
- 9.4 Australia 88
- 9.5 India 90
- 9.6 South Korea 92
- 9.7 Rest of APAC Region 94
- 10 Competitive Landscape 96
- 10.1 Overview of Key Vendors 96
- 10.2 New Product Launch, Partnership, Investment, and M&A 99
- 10.3 Company Profiles 100
- Abbott Laboratories 100
- Astellas Pharma 102
- AstraZeneca Plc 103
- Bayer AG 104
- Bristol Myers Squibb Company 105
- Cipla Inc. 106
- Dr. Reddy’s Laboratories Ltd. 107
- Eli Lilly and Company 108
- F. Hoffmann-La Roche Ltd. 109
- Gilead Sciences, Inc. 110
- GlaxoSmithKline plc. 111
- Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals) 112
- Mayne Pharma Group Ltd. 113
- MELINTA THERAPEUTICS, INC. 114
- Merck KGaA 115
- Novartis AG 116
- Pfizer Inc. 117
- Sanofi 118
- Sun Pharmaceutical Industries Ltd. 119
- 11 Investing in Asia Pacific Market: Risk Assessment and Management 120
- 11.1 Risk Evaluation of Asia Pacific Market 120
- 11.2 Critical Success Factors (CSFs) 123
- Related Reports and Products 126
Table 2. Main Product Trends and Market Opportunities in Asia Pacific Oral Antibiotics Market 30
Table 3. Asia Pacific Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 38
Table 4. Asia Pacific Oral Antibiotics Market: Cephalosporin by Molecule, 2019-2030, $ mn 41
Table 5. Asia Pacific Oral Antibiotics Market by Action Mechanism, 2019-2030, $ mn 49
Table 6. Asia Pacific Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 57
Table 7. Asia Pacific Oral Antibiotics Market by Activity Spectrum, 2019-2030, $ mn 62
Table 8. Asia Pacific Oral Antibiotics Market by Application, 2019-2030, $ mn 66
Table 9. Asia Pacific Oral Antibiotics Market: Dental Infections by Type, 2019-2030, $ mn 69
Table 10. Asia Pacific Oral Antibiotics Market: Respiratory Tract Infections (RTIS) by Type, 2019-2030, $ mn 72
Table 11. Asia Pacific Oral Antibiotics Market by Drug Type, 2019-2030, $ bn 76
Table 12. APAC Oral Antibiotics Market by Country, 2019-2030, $ bn 81
Table 13. Japan Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 85
Table 14. Japan Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 85
Table 15. Japan Oral Antibiotics Market by Application, 2019-2030, $ mn 85
Table 16. China Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 87
Table 17. China Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 87
Table 18. China Oral Antibiotics Market by Application, 2019-2030, $ mn 87
Table 19. Australia Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 89
Table 20. Australia Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 89
Table 21. Australia Oral Antibiotics Market by Application, 2019-2030, $ mn 89
Table 22. India Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 91
Table 23. India Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 91
Table 24. India Oral Antibiotics Market by Application, 2019-2030, $ mn 91
Table 25. South Korea Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 93
Table 26. South Korea Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 93
Table 27. South Korea Oral Antibiotics Market by Application, 2019-2030, $ mn 93
Table 28. Oral Antibiotics Market in Rest of APAC by Country, 2019-2030, $ bn 95
Table 29. Abbott Laboratories: Company Snapshot 100
Table 30. Abbott Laboratories: Business Segmentation 100
Table 31. Abbott Laboratories: Product Portfolio 101
Table 32. Abbott Laboratories: Revenue, 2016-2018, $ mn 101
Table 33. Abbott Laboratories: Recent Developments 101
Table 34. Risk Evaluation for Investing in Asia Pacific Market, 2019-2030 121
Table 35. Critical Success Factors and Key Takeaways 124
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 17
Figure 5. Asia Pacific Oral Antibiotics Market, 2019-2030, $ mn 20
Figure 6. Impact of COVID-19 on Business 21
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Oral Antibiotics Market 23
Figure 8. GDP per capita in the World, 1960-2018, $ thousand 26
Figure 9. Forecast of Middle-class Population by Region, 2015-2030, million 26
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Oral Antibiotics Market 27
Figure 11. Investment Opportunity Analysis 31
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific Oral Antibiotics Market 34
Figure 13. Breakdown of Asia Pacific Oral Antibiotics Market by Drug Class, 2019-2030, % of Revenue 39
Figure 14. Asia Pacific Addressable Market Cap in 2020-2030 by Drug Class, Value ($ mn) and Share (%) 39
Figure 15. Asia Pacific Oral Antibiotics Market: Cephalosporin, 2019-2030, $ mn 40
Figure 16. Asia Pacific Oral Antibiotics Market: Penicillin, 2019-2030, $ mn 42
Figure 17. Asia Pacific Oral Antibiotics Market: Macrolides, 2019-2030, $ mn 43
Figure 18. Asia Pacific Oral Antibiotics Market: Tetracycline, 2019-2030, $ mn 44
Figure 19. Asia Pacific Oral Antibiotics Market: Quinolones, 2019-2030, $ mn 45
Figure 20. Asia Pacific Oral Antibiotics Market: Sulfonamides, 2019-2030, $ mn 46
Figure 21. Asia Pacific Oral Antibiotics Market: Aminoglycosides, 2019-2030, $ mn 47
Figure 22. Asia Pacific Oral Antibiotics Market: Other Drug Classes, 2019-2030, $ mn 48
Figure 23. Breakdown of Asia Pacific Oral Antibiotics Market by Action Mechanism, 2019-2030, % of Sales Revenue 50
Figure 24. Asia Pacific Addressable Market Cap in 2020-2030 by Action Mechanism, Value ($ mn) and Share (%) 50
Figure 25. Asia Pacific Oral Antibiotics Market: Cell Wall Synthesis Inhibitors, 2019-2030, $ mn 51
Figure 26. Asia Pacific Oral Antibiotics Market: Mycolic Acid Inhibitors, 2019-2030, $ mn 52
Figure 27. Asia Pacific Oral Antibiotics Market: RNA Synthesis Inhibitors, 2019-2030, $ mn 53
Figure 28. Asia Pacific Oral Antibiotics Market: DNA Synthesis Inhibitors, 2019-2030, $ mn 54
Figure 29. Asia Pacific Oral Antibiotics Market: Protein Synthesis Inhibitors, 2019-2030, $ mn 55
Figure 30. Asia Pacific Oral Antibiotics Market: Other Mechanisms, 2019-2030, $ mn 56
Figure 31. Breakdown of Asia Pacific Oral Antibiotics Market by Drug Origin, 2019-2030, % of Sales Revenue 58
Figure 32. Asia Pacific Addressable Market Cap in 2020-2030 by Drug Origin, Value ($ mn) and Share (%) 58
Figure 33. Asia Pacific Oral Antibiotics Market: Natural Antibiotics, 2019-2030, $ mn 59
Figure 34. Asia Pacific Oral Antibiotics Market: Semi-synthetic Antibiotics, 2019-2030, $ mn 60
Figure 35. Asia Pacific Oral Antibiotics Market: Synthetic Antibiotics, 2019-2030, $ mn 61
Figure 36. Breakdown of Asia Pacific Oral Antibiotics Market by Activity Spectrum, 2019-2030, % of Revenue 63
Figure 37. Asia Pacific Addressable Market Cap in 2020-2030 by Activity Spectrum, Value ($ mn) and Share (%) 63
Figure 38. Asia Pacific Oral Antibiotics Market: Broad-spectrum Antibiotics, 2019-2030, $ mn 64
Figure 39. Asia Pacific Oral Antibiotics Market: Narrow-spectrum Antibiotics, 2019-2030, $ mn 65
Figure 40. Breakdown of Asia Pacific Oral Antibiotics Market by Application, 2019-2030, % of Revenue 67
Figure 41. Asia Pacific Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 67
Figure 42. Asia Pacific Oral Antibiotics Market: Urinary Tract Infections (UTIS), 2019-2030, $ mn 68
Figure 43. Asia Pacific Oral Antibiotics Market: Dental Infections, 2019-2030, $ mn 69
Figure 44. Asia Pacific Oral Antibiotics Market: Monotherapies for Dental Infections, 2019-2030, $ mn 70
Figure 45. Asia Pacific Oral Antibiotics Market: Combined Therapies for Dental Infections, 2019-2030, $ mn 71
Figure 46. Asia Pacific Oral Antibiotics Market: Respiratory Tract Infections (RTIS), 2019-2030, $ mn 72
Figure 47. Asia Pacific Oral Antibiotics Market: Upper Respiratory Tract Infections (URTI), 2019-2030, $ mn 73
Figure 48. Asia Pacific Oral Antibiotics Market: Lower Respiratory Tract Infections (LRTIs), 2019-2030, $ mn 74
Figure 49. Asia Pacific Oral Antibiotics Market: Other Applications, 2019-2030, $ mn 75
Figure 50. Breakdown of Asia Pacific Oral Antibiotics Market by Drug Type, 2019-2030, % of Revenue 76
Figure 51. Asia Pacific Addressable Market Cap in 2020-2030 by Drug Type, Value ($ bn) and Share (%) 77
Figure 52. Asia Pacific Oral Antibiotics Market: Brand Antibiotics, 2019-2030, $ bn 78
Figure 53. Asia Pacific Oral Antibiotics Market: Generic Antibiotics, 2019-2030, $ bn 79
Figure 54. Breakdown of APAC Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 81
Figure 55. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 82
Figure 56. Oral Antibiotics Market in Japan, 2019-2030, $ bn 84
Figure 57. Oral Antibiotics Market in China, 2019-2030, $ bn 86
Figure 58. Oral Antibiotics Market in Australia, 2019-2030, $ bn 88
Figure 59. Oral Antibiotics Market in India, 2019-2030, $ bn 90
Figure 60. Oral Antibiotics Market in South Korea, 2019-2030, $ bn 92
Figure 61. Oral Antibiotics Market in Rest of APAC, 2019-2030, $ bn 94
Figure 62. Growth Stage of Asia Pacific Oral Antibiotics Industry over the Forecast Period 96
Related Reports
Allows one individual to access the purchased report Read More
Allows all employees of an organization to access the purchased report. Internal sharing only Read More
Allows all employees of an organization to access the purchased report. It also permits the use of up to 4 paragraphs or 1 page of the report externally in whitepapers, press releases, and marketing collateral Read More
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (27 July, 2024)
- Notify To Team (27 July, 2024)
- Report updation (28 July, 2024)
- Report Quality Check (28 July, 2024)
- Report Dispatch (29 July, 2024)
- Hard Copy
Recently Viewed Products
Asia Pacific Oral Antibiotics Market 2020-2030
We are friendly and approachable, give us a call.